iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 4,020.00
+205.00 (5.37%)
Jan 29, 2026, 3:30 PM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 123.23 billion as of January 29, 2026. Its market cap has decreased by -32.87% in one year.
Market Cap
123.23B
Enterprise Value
88.30B
Revenue
5.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,020.00
Market Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 123.23B, an increase of 29.31%. That is a compound annual growth rate of 1.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 116.95B | 13.82% |
| Dec 30, 2025 | 102.75B | -44.03% |
| Dec 30, 2024 | 183.56B | -37.01% |
| Dec 28, 2023 | 291.42B | 7.98% |
| Dec 29, 2022 | 269.88B | -61.99% |
| Dec 30, 2021 | 710.00B | -22.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EASY BIO,Inc. | 233.23B |
| MedPacto | 226.56B |
| Genexine | 226.49B |
| ENCell | 185.73B |
| Macrogen | 184.85B |
| GeneOne Life Science | 156.77B |
| IMB Dx | 134.43B |
| Oncocross | 114.46B |